Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500110226Phase 4Not yet recruiting
Phase 4, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by The First People's Hospital of Kunshan. Primary endpoint: Area under the pain score curve 25–72 hours after surgery. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500110226.